14800-DvRappard

172 Chapter 10 14. Buizer AI, van Schie PE, Bolster EA, van Ouwerkerk WJ, Strijers RL, van de Pol LA, et al. Effect of selective dorsal rhizotomy on daily care and comfort in non-walking children and adolescents with severe spasticity. Eur J Paediatr Neurol. 2017;21:350-357. 15. Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, et al. Consensus statement on preventive and symptomatic care of leukodystrophy patients. Mol Genet Metab. 2015;114:516-526. 16. Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta- analysis. Curr Med Res Opin. 2004;20:981-990. 17. Penati R, Fumagalli F, Calbi V, Bernardo ME, Aiuti A. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I. J Inherit Metab Dis . 2017;40:543-554. 18. Sessa M, Lorioli L, Fumagalli F, Acquati S, Redaelli D, Baldoli C, et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. Lancet. 2016;388(10043):476-487. 19. Waggoner DJ, Tan CA. Expanding newborn screening for lysosomal disorders: opportunities and challenges. Dev Disabil Res Rev. 2011;17:9-14. 20. Orsini JJ, Kay DM, Saavedra-Matiz CA, Wenger DA, Duffner PK, Erbe RW, et al. Newborn screening for Krabbe disease in New York State: the first eight years' experience . Genet Med. 2016;18:239-248. 21. RosenbergJB,KaminskySM,AubourgP,CrystalRG,SondhiD.Genetherapyformetachromatic leukodystrophy. J Neurosci Res. 2016;94:1169-1179.